|
Diane Goostree, chief executive officer of Artes Medical, Inc., rings the opening bell. |
| |

Diane Goostree, chief executive officer of Artes Medical, Inc. and Christopher Reinhard, Chairman, ring the opening bell. |
Diane Goostree, chief executive officer of Artes Medical, Inc., rings the opening bell.
Tuesday March 27, 2007
at Nasdaq's MarketSite
in Times Square, New York
Artes Medical, Inc. [ARTE]
|
| |
Additional Photographs & Reprint Permissions
Archived MarketSite Events | Summary Quote
Diane Goostree, chief executive officer of Artes Medical, Inc. and Christopher Reinhard, Chairman of Artes Medical, Inc., preside over the opening bell to celebrate the Company's recent initial public offering on NASDAQ.
Artes Medical, Inc. [ARTE]:
Artes Medical is a medical technology company focused on developing, manufacturing and commercializing a new category of aesthetic injectable products for the dermatology and plastic surgery markets.
There were approximately two million dermal filler procedures in the U.S. in 2006, an increase of 25% over the prior year, according to the American Society of Aesthetic Plastic Surgeons, or ASAPS. The Company's initial product, ArteFill(r), is being marketed to men and women as a treatment option for the correction of nasolabial folds. Additional information about Artes Medical and ArteFill is available at www.artesmedical.com and www.artefill.com.
Reprints
Click for larger pictures of the NASDAQ MarketSite.
Additional Photographs for 03/27/2007
© Copyright 2007, The NASDAQ Stock Market, Inc.
Reprinted with the permission of The Nasdaq Stock Market, Inc. |
|